LANCOME PARIS CLARIFIQUE BX-INTERCEPTOR TOPICAL ACNE CLEARING TREATMENT- salicylic acid liquid

Lancome Paris Clarifique BX-Interceptor Topical Acne Clearing Treatment by

Drug Labeling and Warnings

Lancome Paris Clarifique BX-Interceptor Topical Acne Clearing Treatment by is a Otc medication manufactured, distributed, or labeled by L’Oreal USA Products Inc, SICOS ET CIE. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient

Salicylic acid 2%

Purpose

Acne treatment

Uses

• for the treatment of acne
• helps clear up acne blemishes and allows skin to heal

Warnings

For external use only.

Flammable until dry.

Do not use near fire, flame or heat.

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• clean the skin thoroughly before applying this product
• cover the entire affected area with a thin layer one to three times daily
• because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
• if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Inactive ingredients

water, panthenol, glycerin, alcohol denat., niacinamide, glycolic acid, sodium hydroxide, bixa orellana seed extract, ananas sativus (pineapple) fruit extract, fagus sylvatica bud extract, papain, potassium azeloyl diglycinate, PPG-26-buteth-26, PEG-32, PEG-40 hydrogenated castor oil, propanediol, copper gluconate, hydroxyethylcellulose, citric acid, trisodium ethylenediamine disuccinate, lactic acid, maltodextrin, phytic acid, polyquaternium-10, sorbic acid, benzoic acid, fragrance

Questions or comments?

1-800-LANCOME (1-800-526-2663)

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

LANCOME PARIS CLARIFIQUE BX-INTERCEPTOR TOPICAL ACNE CLEARING TREATMENT 
salicylic acid liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 82046-955
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	20 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
PANTHENOL (UNII: WV9CM0O67Z)
GLYCERIN (UNII: PDC6A3C0OX)
ALCOHOL (UNII: 3K9958V90M)
NIACINAMIDE (UNII: 25X51I8RD4)
GLYCOLIC ACID (UNII: 0WT12SX38S)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
BIXA ORELLANA SEED (UNII: O87354RZ5A)
PINEAPPLE (UNII: 2A88ZO081O)
FAGUS SYLVATICA FLOWER BUD (UNII: 6D5V13045W)
PAPAIN (UNII: A236A06Y32)
POTASSIUM AZELOYL DIGLYCINATE (UNII: N02RVN6NYP)
PPG-26-BUTETH-26 (UNII: 2II1K6TZ4P)
PEG-32 (UNII: 1212Z7S33A)
PEG-40 HYDROGENATED CASTOR OIL (UNII: 7YC686GQ8F)
PROPANEDIOL (UNII: 5965N8W85T)
COPPER GLUCONATE (UNII: RV823G6G67)
HYDROXYETHYLCELLULOSE (UNII: T4V6TWG28D)
CITRIC ACID (UNII: 2968PHW8QP)
TRISODIUM ETHYLENEDIAMINE DISUCCINATE (UNII: YA22H34H9Q)
LACTIC ACID (UNII: 33X04XA5AT)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
PHYTIC ACID (UNII: 7IGF0S7R8I)
POLYQUATERNIUM-10 (400 MPA.S AT 2%) (UNII: HB1401PQFS)
SORBIC ACID (UNII: X045WJ989B)
BENZOIC ACID (UNII: 8SKN0B0MIM)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 82046-955-01	1 in 1 CARTON	03/02/2026
1		30 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	03/02/2026

Labeler - L’Oreal USA Products Inc (002136794)

Establishment
Name	Address	ID/FEI	Business Operations
SICOS ET CIE		276993581	manufacture(82046-955) , pack(82046-955)